•
Sep 30, 2022

American Vanguard Q3 2022 Earnings Report

Reported a 3.4% increase in net sales, a 21.8% increase in net income, and a 27.8% increase in earnings per diluted share for the third quarter of 2022.

Key Takeaways

American Vanguard reported strong Q3 2022 results, with net sales reaching $152 million, a 3.4% increase compared to Q3 2021. Net income increased by 21.8% to $6.7 million, and earnings per diluted share rose by 27.8% to $0.23. The company's performance was driven by growth in the US Crop business and strong international sales, particularly in Brazil and Mexico.

Net sales increased by 3.4% to $152 million compared to Q3 2021.

Net income increased by 21.8% to $6.7 million compared to Q3 2021.

Earnings per diluted share increased by 27.8% to $0.23 compared to Q3 2021.

Adjusted EBITDA increased by 11.2% to $18.9 million compared to Q3 2021.

Total Revenue
$152M
Previous year: $147M
+3.3%
EPS
$0.23
Previous year: $0.18
+27.8%
Gross Profit
$61.4M
Previous year: $57.1M
+7.6%
Cash and Equivalents
$20.8M
Previous year: $16.7M
+24.5%
Total Assets
$776M
Previous year: $736M
+5.5%

American Vanguard

American Vanguard

American Vanguard Revenue by Segment

American Vanguard Revenue by Geographic Location

Forward Guidance

American Vanguard expects significant year-end debt reduction and a full-year adjusted EBITDA of approximately $80 million or 13% of expected sales. The company continues to pursue strategic growth initiatives to expand its core business and develop new technologies.

Positive Outlook

  • Expects significant year-end debt reduction
  • Full-year adjusted EBITDA of approximately $80 million
  • Strategic growth initiatives to expand core business
  • Development of new technologies
  • Alliance with NewLeaf Symbiotics to complement biological portfolio

Revenue & Expenses

Visualization of income flow from segment revenue to net income